DEXCOM INC is 14.8x more valuable than NovoCure Ltd by market capitalization ($28.85 B vs $1.94 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | NVCR | DXCM |
|---|---|---|
| Market cap | $1.94 B | $28.85 B |
| US-listed rank | #2114 | #473 |
| Revenue (latest FY) | $655.35M | $4.66B |
| Net income (latest FY) | -$136.23M | $836.30M |
| Net margin | -20.8% | 17.9% |
| P/E (trailing FY) | - | 34.5 |
| SEC filings | 1,138 | 2,566 |
DEXCOM INC is 14.8x more valuable than NovoCure Ltd by market capitalization ($28.85 B vs $1.94 B).
In their latest fiscal years, NovoCure Ltd reported $655.35M in revenue while DEXCOM INC reported $4.66B.
Full pages: NovoCure Ltd and DEXCOM INC, or browse the full rankings.